Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID)

COVID-19 vaccine boosters not only protect against SARS-CoV-2 – the virus behind the most recent pandemic – but may also help protect against some...

A drug commonly used to treat epilepsy could be repurposed to significantly boost the response to vaccines in humans, helping protect those for whom...

Eight scientists from the fields of biomedical and health research at the University of Cambridge have been elected as Fellows of the Academy of...

The mpox virus appears to be circulating silently in parts of Nigeria, in many cases without the symptoms typically associated with the disease...

Bird flu viruses are a particular threat to humans because they can replicate at temperatures higher than a typical fever, one of the body’s ways of...

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the...

Monoclonal antibodies – treatments developed by cloning a cell that makes an antibody – could help provide an answer to the growing problem of...

Nine Cambridge researchers are among the latest recipients of highly competitive and prestigious European Research Council (ERC) Starting Grants.

Problems with iron levels in the blood and the body’s ability to regulate this important nutrient as a result of SARS-CoV-2 infection could be a key...